🧬 biology

SNAPC4-related neurodevelopmental disorder defines a stage-dependent spliceosomopathy with heterogeneous clinical trajectories

This study characterizes SNAPC4-related neurodevelopmental disorder as a heterogeneous, stage-dependent spliceosomopathy caused by loss-of-function variants that destabilize the SNAPc complex and disrupt snRNA transcription, leading to a wide spectrum of clinical and neuroimaging abnormalities.

Original authors: Marcello Scala, Mohammad Sadegh Shams Nosrati, Alexandra Ruffus, Alireza Dostmohammadi, Amir Hesam Nemati, Francesca Madia, Chiara Fiorillo, Farooq Ahmed, MUHAMMAD UMAIR, Guillaume Banneau, Sophie Jul

Published 2026-07-22

📖 3 min read☕ Coffee break read

CC BY 4.0

Original authors: Marcello Scala, Mohammad Sadegh Shams Nosrati, Alexandra Ruffus, Alireza Dostmohammadi, Amir Hesam Nemati, Francesca Madia, Chiara Fiorillo, Farooq Ahmed, MUHAMMAD UMAIR, Guillaume Banneau, Sophie Julia, Run Fridriksdottir, Lesley Turner, Cassidy Welsh, Madeleine Franchi, Amy Espinal, Dandan He, Soma Das, Christopher Gomez, Daniel Calame, May Christine Malicdan, Marie Morimoto, Janna hol, Cynthia Silveira, França Jr Marcondes Cavalca, Carelis González-Salavaz, Caleb Bupp, Maddie Donald, Joseph Junewick, Albena Todorova, Mila Sleptsova, Daniela Avdjieva - Тzavella, Radka Maslarska, Vanyo Mitev, David Genevieve, Jérémie Mortreux, Mohammed Salah, Salem Alawbathani, Murtadha Ali, Gabriela Oprea, Morteza Doustmohammadi, Zahra Hoseini Tavassol, Monica Traverso, Michele Iacomino, Patrizia De Marco, Mahsa Boogari, Davood Omrani, Ferruccio Romano, Valeria Capra, Stephen Scherer, Filippo Santorelli, Sara Satolli, Amy Crunk, Auragen Consortium, Federico Zara, Takuya Sakaguchi

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine your body is a massive, bustling city where billions of tiny construction crews are constantly building and repairing houses, roads, and bridges. To keep this city running, the city hall needs to send out millions of specific blueprints every single day. In our bodies, these blueprints are called RNA, and the city hall is the cell's nucleus. But here's the catch: the blueprints don't come out perfectly formatted. They arrive as long, messy scrolls that need to be edited, cut, and taped together before they can be used. This editing process is called "splicing," and it's managed by a super-efficient machine called the spliceosome.

Now, imagine the spliceosome is a high-tech printing press. For this press to work, it needs a specific team of workers to set it up and tell it which blueprints to print. One of the most important workers in this team is a protein called SNAPC4. Think of SNAPC4 as the foreman who holds the master plan. It grabs the printing press (the cell's machinery) and locks it onto the correct starting point so the blueprints can be made. If this foreman is missing or broken, the printing press doesn't know where to start, the blueprints get messed up, and the construction crews in the city (your brain and body) start building things wrong or stop building altogether. Scientists have long known that when SNAPC4 is broken, it causes severe problems with how the brain develops, but they weren't sure exactly how the "broken foreman" changed the story for different people.

This paper is like a detective story where a team of researchers from all over the world joined forces to solve a mystery about what happens when SNAPC4 goes wrong. They gathered information on 14 different people who have a broken SNAPC4 gene and found that the story is much more complicated—and interesting—than anyone thought. Instead of a single, predictable tragedy where everyone gets worse and worse, they discovered a "spectrum" of outcomes. For some, the brain development issues are present from birth but stay the same (static). For others, the problems start slowly and get worse over time (progressive), and for a few, the issues don't show up until adulthood.

The researchers also looked at the "blueprints" (the DNA mutations) to see how they broke the foreman. They found 18 different ways the gene could be broken, ranging from tiny typos to missing chunks of the instruction manual. Using computer models, they showed that these broken versions of SNAPC4 either fall apart (destabilize) or can't grab onto the printing press properly. To test this in real life, they used tiny zebrafish. Fish with a broken SNAPC4 gene looked normal on the outside, but when the researchers watched them swim, the fish moved much less than their healthy siblings. This proved that even if the body looks okay, the brain's "motor control" is struggling.

The big takeaway is that SNAPC4-related disease isn't just one thing. It's a lifelong journey that can look very different for every person. Some people might have autism or ADHD, while others might have trouble walking or speaking. Some might have heart or liver issues, while others don't. The paper suggests that the severity depends on how the foreman is broken and when the brain needs that specific blueprint the most. By understanding these different paths, doctors might be able to better predict what a patient needs and how to help them, turning a confusing medical mystery into a clearer map for the future.

Technical Summary: SNAPC4-related neurodevelopmental disorder defines a stage-dependent spliceosomopathy with heterogeneous clinical trajectories

Problem Statement
The small nuclear RNA-activating complex polypeptide 4 (SNAPC4) encodes the largest scaffolding subunit of the SNAPc complex, which is essential for the transcription of spliceosomal small nuclear RNAs (snRNAs) by RNA polymerases II and III. While pathogenic variants in SNAPC4 were previously associated with a rare autosomal recessive disorder characterized by severe neurodevelopmental delay, psychomotor regression, and progressive spastic paraparesis (NEDRSO), the full phenotypic spectrum and molecular mechanisms remained poorly defined. Previous literature suggested a uniformly progressive neurodegenerative course, but the extent of clinical heterogeneity, the impact of diverse missense variants on SNAPc architecture, and the potential for non-progressive phenotypes were unknown.

Methodology
The authors assembled an international cohort of 14 individuals from independent families harboring 18 distinct pathogenic SNAPC4 variants (including three previously reported). The study employed a multi-modal approach:

Clinical and Genetic Characterization: Deep phenotyping was conducted using standardized Human Phenotype Ontology (HPO) terminology, integrating retrospective clinical data, neuroimaging (MRI), and exome sequencing. Variants were classified according to ACMG/AMP 2015 criteria with ClinGen refinements.
In Silico Structural and Functional Analysis: Due to the lack of an experimentally determined structure for the 1,469-amino-acid SNAPC4 protein, the study utilized AlphaFold2-predicted models. Protein stability changes ( $\Delta\Delta G$ ) were predicted using ThermoMPNN, while pathogenicity was assessed via SIFT, PolyPhen-2, and CADD. Protein-protein interaction (PPI) effects were modeled using mCSM-PPI2 and DDMut-PPI on resolved SNAPc-containing pre-initiation complexes (bound to U1 and U5 snRNA promoters).
In Vivo Functional Validation: The study utilized a snapc4 mutant zebrafish model (snapc4^s445^), which carries a premature stop codon truncating the C-terminal SNAPC2-binding domain. Locomotor activity was quantified in 120 hours post-fertilization (hpf) larvae using automated motion detection to assess neuromotor function in the absence of overt morphological defects.

Key Results

Clinical Heterogeneity: The cohort revealed that SNAPC4-related disease is not a uniform progressive disorder but a heterogeneous clinical continuum. While global developmental delay (GDD) and microcephaly are core features, disease trajectories vary significantly:
- Static Phenotypes: Four individuals (Cases 2, 3, 10, 12) exhibited static GDD or mild cognitive impairment without psychomotor regression.
- Progressive Phenotypes: Some individuals showed childhood-onset regression, while others (e.g., Case 8) presented with adult-onset progressive spastic paraparesis and bulbar dysfunction after achieving normal early milestones.
- Neurobehavioral Spectrum: The study identified significant neurobehavioral involvement previously underrecognized, including autism spectrum disorder (ASD), ADHD, severe behavioral dysregulation (self-injury, insomnia), and anxiety, which appeared independent of motor severity.
Neuroimaging Diversity: MRI findings ranged from normal brain architecture to severe malformations. Specific abnormalities included lissencephaly-pachygyria (suggesting impaired neurogenesis/migration), hypomyelinating leukodystrophy (suggesting impaired gliogenesis), and progressive atrophy of the cerebellum and basal ganglia. Notably, some individuals with severe clinical phenotypes had normal MRIs.
Genetic Landscape: The 18 variants included nonsense, frameshift, canonical splice-site, and missense mutations, as well as a multi-exon deletion. Loss-of-function (LoF) variants were predominant, often occurring in compound heterozygosity with missense alleles.
Structural Mechanisms: In silico modeling indicated that pathogenic variants converge on a loss-of-function mechanism. Missense variants were predicted to destabilize the SNAPC4 protein or disrupt critical interfaces required for DNA binding (Myb domains) and protein-protein interactions (SNAPC2 binding regions). Specifically, variants in the C-terminal region were shown to reduce affinity for SNAPC2, potentially impairing complex assembly while preserving DNA binding.
Zebrafish Phenotype: snapc4^s445^ mutant larvae displayed a marked reduction in spontaneous locomotor activity compared to wild-type siblings, despite lacking overt gross morphological abnormalities. This confirms that snapc4 loss impairs neuromotor function in vivo.

Significance and Claims
The paper redefines SNAPC4-related disease as a "stage-dependent neurodevelopmental spliceosomopathy." The authors claim that the disorder represents a lifelong continuum rather than a strictly infantile neurodegenerative condition. The findings suggest that the severity and timing of the phenotype depend on the specific molecular disruption:

Severe disruptions to complex stability or promoter engagement likely cause early defects in corticogenesis and migration (e.g., lissencephaly).
Milder perturbations may allow for early development but fail under the increased transcriptional demands of mature neurons, leading to later-onset regression, spasticity, or psychiatric manifestations.
The study links the disruption of SNAPC4 to impaired snRNA transcription and subsequent splicing dysregulation, affecting neuronal transport, synaptic maintenance, and cytoskeletal organization.
The identification of systemic involvement (e.g., hepatic steatosis and hyperinsulinemia in one case) parallels findings in zebrafish models, suggesting broader developmental effects beyond the central nervous system.

The authors conclude that this expanded understanding has direct implications for diagnosis, variant interpretation, and the expectation of clinical trajectories, emphasizing that SNAPC4 deficiency affects both basal transcriptional machinery and selective neuronal vulnerability across different developmental stages.

More like this